Skip to main content
Clinical Trials/NCT04716790
NCT04716790UnknownNot Applicable

Randomized Clinical Trial to Elucidate the Effects of Low Frequency Ultrasound Debridement (LFU), in Patients With Diabetic Foot Ulcers, Compared to Its Conventional Treatment

Universidad Complutense de Madrid1 site in 1 country60 target enrollmentStarted: April 20, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
60
Locations
1
Primary Endpoint
Healing Rate

Study Overview

Brief Summary

The investigators aimed to elucidate the effects of ultrasound debridement on the area and healing of diabetic foot ulcers compared to their conventional treatment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Investigator)

Masking Description

The clinician who performs the cures, photographs and data collection is different from the clinician who performs the application of ultrasound debridement. Therefore, the evaluator will be blinded.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Male and female patients ≥18 years old.
  • •Type 1 or type 2 diabetes mellitus with HbA1c ≤ 10%.
  • •DFU grades IA, IIA, IB, IIB, IC, IIC, ID, IID, according to the University of Texas Classification.
  • •DFU grades PEDIS 1-Absence of Infection, PEDIS 2-Mild infection and PEDIS 3-Moderate infection, according to the PEDIS-IDSA Classification.
  • •Wound size between 1 cm² and 30 cm².
  • •Evolution time DFU between 1 and 24 months.
  • •Ankle-brachial index (ABI) ≤0.9 and ankle systolic blood pressure (ASBP) ≥70mmHg, or toe systolic blood pressure (TSBP) ≥50mmHg, ABI>0.9, TSBP ≥50mmHg and toe-brachial index (TBI) ≤0.7

Exclusion Criteria

  • •Critical limb ischemia patients with ABI≤0.5 and ASBP<70mmHg or TSBP<50mmHg.
  • •Clinical suspicion of osteomyelitis.
  • •Pregnant or lactating women or women of childbearing potential who are not using effective contraception.
  • •Patients diagnosed with hepatitis or human immunodeficiency virus (HIV)

Arms & Interventions

Ultrasounds once a week

Experimental

Patients will undergo the application of ultrasound therapy with a frequency of once a week.

Intervention: Ultrasound Debridement (Procedure)

Ultrasounds once every two weeks

Experimental

Patients will undergo the application of ultrasound therapy with a frequency of once every two weeks.

Intervention: Ultrasound Debridement (Procedure)

Standard of care

Active Comparator

Patients will be treated using the conventional treatment established by the protocol of the Diabetic Foot Unit of the University Podiatry Clinic of Complutense University of Madrid.

Intervention: Conventional Treatment (Procedure)

Outcomes

Primary Outcomes

Healing Rate

Time Frame: 12 weeks

Total epithelialization of the wound.

Healing Time

Time Frame: 12 weeks

Time from the inclusion of the wound in the study until its total epithelialization.

Wound Size

Time Frame: 12 weeks

Planimetric measurements of wound size will be made using Visitrak (Smith \& Nephew, Hull, UK).

Secondary Outcomes

  • Transcutaneous oxygen pressure (TcPO2)(baseline and week 7)
  • Health-related quality of life(baseline and 12 week)
  • Wound Conditions(12 weeks)
  • Pain intensity(12 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sebastian Flores Escobar

Principal Investigator

Universidad Complutense de Madrid

Study Sites (1)

Loading locations...

Similar Trials